Document is current
Any future updates will be listed below
-
Authors
Currie, Gillian R. https://orcid.org/0000-0002-4681-9893
Groothuis-Oudshoorn, Catherina G.M.
Twilt, Marinka
Kip, Michelle M. A.
IJzerman, Maarten J.
Benseler, Susanne M.
Swart, Joost F.
Vastert, Sebastiaan J.
Wulffraat, Nico M.
Yeung, Rae
Marshall, Deborah A
-
Funding
Funding for this research was provided by:
Canadian Institutes for Heath Research (381280)
Genome Canada (OGI-150)
ZonMw
Reumafonds (848006001)
Arthritis Society of Canada (GC-18-001)
Genome Alberta
Ontario Genomics
- License Information
-
More Information
Article History
Received: 7 October 2022
Revised: 31 March 2023
Accepted: 27 April 2023
First Online: 19 May 2023
Declarations
:
: DM reports grants from Canadian Institutes of Health Research, Alberta innovates, and the Arthritis Society supports for attending meetings from Illumina and ISPOR, and consulting fees from Analytica. All are outside of the submitted work.RY reports consulting fees from Novartis and Lily, outside the submitted work.SV reports grants and personal fees from SOBI and Novartis during the conduct of the study, outside the submitted work.JS reports consulting fees from Amgen, outside the submitted work.NW reports honoraria from UBC for a lecture on vaccinations.All other authors declare that they gave no competing interests.
: There was no direct patient involvement in this component of the research.
